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PROFILE OF RENAL DISEASES IN HIV 
INTRODUCTION 
                 AIDS was first recognized in united states in 1981 when evaluated for Pneumocystis  
jiroveci infection and Kaposi sarcoma  in homosexuals. In 1983 HIV virus was isolated from a patient 
with lymphadenopathy, and in 1984 it was demonstrated as cause of AIDS. The evolution of HIV 
pandemic was matched by explosive informations in areas of HIV virology, pathogenesis, treatment of 
HIV, opportunistic infections, prevention of infections, and toxicity of drugs used for HIV and 
opportunistic infections. As early as in 1984 itself physicians of New York and Miami recognized 
Kidney disease as a devastating complication of AIDS.   
 Literature of HIV and Renal Lesions is reviewed extensively and the study of this dissertation 
is presented. 
Review of literature and background of this study 
I. HIV Epidemiology and     HIV Etiopathogenesis 
II. Renal pathogenesis   
           1) Genetics 
           2) Mechanism of Renal Infection 
           3) Role of HIV-1 Infection of Renal Epithelial Cells 
           4) Kidney as a reservoir for HIV-1 
           5) HIVAN is caused by HIV Infection of Renal Epithelial Cells 
           6) Viral Factors: Nef, Vpr, TAT 
           7) Factors Promoting Apoptosis and Fibro genesis 
        8) Inflammatory Mediators   
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        9) Proliferation   
       10) Mediators of Cell Adhesion, Cell Signaling, and Extra cellular Matrix 
III. Clinical Profile of Renal Lesions in HIV        
      1.Acute renal failure 
      a) Pre Renal causes  
b) Intrinsic Renal Injury 
       c) Post Renal causes 
       d) Risk Factors for AKI in HIV 
       e) Acute Renal Failure due to Medications  
     f) Diffuse Infiltrative Lymphocytosis Syndrome (DILS) 
   2. Fluid and Electrolyte Disorders 
          a) Hyponatremia 
          b) Hypokalemia 
          c) Hyperkalemia 
    3. Chronic kidney Disease 
           a) HIVAN  
           b) HIV related Immune Complex Glomerulo Nephritis 
           c) Hemolytic Uremic Syndrome 
           d) Chronic Interstitial Disorders -Drugs 
           e) Non HIV Related Diseases in HIV patients                     
    4. End Stage Renal Disease 
    5. Renal Replacement Therapy 
        a) Hemodialysis 
        b)  Peritoneal Dialysis 
 5 
        c) Kidney Transplantation 
 
AIM of the Study 





HIV Epidemiology  
The UNAIDS statistics reports that the estimated people living with HIV/AIDS in 2008 was 
33.4 million, of this adults were 31.3million, and women 15.7 million, 2.1 million were children, 
newly infected in 2008 were 2.7million and death in 2008 was 2 million, and more than 25million 
people died of AIDS since 1981. In developing and transitional countries, 9.5 million people are in 
immediate need of life-saving AIDS drugs, of these, only 4 million (42%) are receiving the drugs. 
India has a population of more than one billion, around half of whom are adults in the sexually active 
age group. The first case of AIDS in India was detected in 1986 and since then HIV infection has been 
reported from all states and union territories. Spread of HIV in India has been uneven .The highest 
HIV prevalence rates are found in Andhra Pradesh, Maharashtra, TamilNadu and Karnataka in the 
south; and Manipur and Nagaland in the north-east. In the southern states, HIV is primarily spread 
through heterosexual contact. Infections in the north-east are mainly found amongst injecting drug 
users and sex workers. Indian government AIDS control organization NACO in 2008 reported that 
people with HIV/AIDS living in India in 2007 was 2.31 million, 39% are females with a prevalence of 







AIDS is caused most commonly by Human Immunodeficiency viruses HIV I, and also by HIV 
II viruses. They belong to human retrovirus family, and sub family of lentiviruses and they are RNA 
cytopathic viruses.  HIV virion is isosahedral in structure contains numerous external spikes formed 
by two major envelope proteins gp120 and gp41.They are transmitted through sexual contacts, body 
fluids, during pregnancy, delivery and breast feeding .The replication of virions begin with binding of 
gp120 with CD4 molecule through its Vi region. CD4 present in CD4 T lymphocytes, 
monocytes/macrophges and dentritic/langerhans cells. Once gp120 binds with CD4, gp120 undergoes 
conformational changes and binds also with one of a group of co-receptors.  
Two major co-receptors for HIV I are CCR5 and CXCR4, responsible for cellular tropism of 
viruses. Fusion with cell membrane occurs via newly exposed gp41, and preintegration complex 
composed of viral RNA, viral enzymes, surrounded by capsid is released into cytoplasm. In the 
cytoplasm viral reverse transcriptase catalyses reverse transcription of viral RNA into double stranded 
HIV DNA which is exported through nuclear pore into nucleus. And integrated with introns of active 
genes of nuclear DNA by the virally encoded integrase, and transcription of integrated proviral DNA 
into genomic RNA or mRNA occurs. HIV mRNA is translated into proteins that undergo 
glycosylation, myristalisation, phosphorylation and cleavage. The viral particle is formed by assembly 
of HIV proteins enzymes, and genomic RNA at the plasma membrane of cells. Budding of virions 
through lipid rafts in lipid bilayer of host cell membrane where core acquires the envelope. 
HIV-I has genes that encode structural proteins of the virus; gag encodes proteins that form 
core including p24. Pol encodes for the enzyme of proteases, reverse transcriptase, and integrase. The 
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gene env codes for envelope glycoprotein. Six other genes tat, rev, nef, vpr, vif and vpu encode for 
proteins involved in modification of host cell to enhance cell growth and regulate viral gene 
expression.  Transcription activation factor p14 bind TAR in the presence of host cyclin and   CDk 9 
and enhance RNA pol II elongation in the viral envelope, and rev inhibits viral RNA splicing and 
promote export of incompletely spliced viral RNAs nef encode for negative factor p27 which 
promotes down regulation of CD4 and MHC1 expression, blocks apoptosis, enhance virion infectivity, 
and alters state of cellular activation. The vpr gene promotes G2 cell cycle arrest and facilitates HIV 
infection of macrophages. The gene vif encodes for p23 which is a viral infectivity factor, which 
overcomes the inhibitory effects of APOBEC preventing hypermutation and viral DNA degradation. 
The vpu gene encodes viral protein U which promotes CD4 degradation and influence virion release. 
Long terminal repeat (LTR) codes for control regions that bind with host transcription factors NF-kB, 
NFAT.sp-1 and TBP. 
          The hallmark of HIV disease is profound immunodeficiency results primarily from quantitative 
and qualitative deficiency of CD4 T helper cells. Patients with CD4 count below 200cell/ml become 
susceptible to opportunistic infections, and the definition of AIDS includes all HIV patients below this 
level. HIV virus enters the blood stream enters spleen and other lymphoid organs where primary 
infection begins, followed by wider dissemination throughout other lymphoid tissue particularly in the 
Gut  associated lymphoid tissue (GALT) where  the establishment of chronic and persistent infection 
occurs. Sustained level of replication viral diversity via mutation, inability to contain quasi species 
with antibodies, down regulation of HLA I on the surface of infected cell by nef protein of HIV, and 
evasion of response to antibody because of hypervariablity of primary sequence of envelope, extensive 
glycosylation of envelope, conformational masking of neutralizing epitopes all contribute to the 
progression of HIV infection. 
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Renal Pathogenesis:    Disease of kidney in HIV may be a direct consequence of HIV infection, due 
to opportunistic infections, neoplasm or drug related toxicity and other factors as in general 
population. The literature was reviewed in the following headings. 
 1) Genetics 
 2) Mechanism of Renal Infection 
 3) Role of HIV-1 Infection of Renal Epithelial Cells 
 4) Kidney as a Reservoir for HIV-1 
 5) HIVAN is caused by HIV Infection of Renal Epithelial Cells 
 6) Viral Factors: Nef, Vpr, TAT 
 7) Factors Promoting Apoptosis and Fibro Genesis  
 8) Inflammatory Mediators 
 9) Proliferation. 
 10) Mediators of Cell Adhesion, Cell Signaling, and Extra cellular Matrix 
  Genetics  
The reason behind the increased predilection among black persons for the development of 
HIV-associated nephropathy is not clear. In general, black persons have a higher incidence of other 
renal diseases (e.g., diabetic nephropathy, lupus, abuse).Therefore they may have an underlying 
genetic predisposition to severe renal disease, regardless of the etiology. The type of host response to 
the HIV infection itself may determines whether or not nephropathy develops in a specific individual. 
Although HIV infection of the renal epithelium is a necessary step in HIVAN pathogenesis, only 
genetically susceptible persons respond to this infection by developing HIVAN. The host response to 
HIV infection is therefore a critical determinant in the pathobiology of HIVAN. Although genetic 
factors clearly contribute to the susceptibility of blacks to HIVAN, these factors remain unknown. 
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However, several studies have identified features of the response of renal epithelial cells to HIV gene 
expression that contribute to the development of progressive renal disease. 
Mechanism of HIV-1 Renal InfectionThe mechanism by which HIV-1 enters renal epithelial cells 
remains unknown. The virus infects lymphocytes and macrophages via interaction of the viral 
envelope protein gp120 with the cellular CD4 receptor and either the CXCR4 or CCR5 co-receptor.  
Conaldi et al detected CXCR4 and CD4 in a subpopulation of cultured renal epithelial cells, 
suggesting that HIV-1 may infect renal epithelial cells via these receptors. Ray et al reported infection 
of primary renal tubular epithelial cells (RTECs) using HIV isolated from the Periphral Blood 
Mononuclear Cells (PBMC) of children with HIVAN. The addition of a CD4 antibody did not inhibit 
infection, suggesting that RTEC infection by renal tropic HIV virus may occur via a CD4 independent 
mechanism. Another group found that the kidney-derived viruses were capable of infecting cells 
expressing CD4 and either CXCR4 or CCR5, whereas the blood-derived viruses could infect only 
CCR5-expressing cells. The investigators also showed that kidney-derived isolates were able to infect 
cell lines using the alternate HIV co-receptors BONZO/STRL33 and   BOB/GPR15.   
A recent study reported that the C-type lectin DEC-205 can mediate internalization and 
nonproductive infection of the HK-2–immortalized tubular cell line. Taken together, these studies 
suggest that there may be renal tropic strains of HIV and the receptor use of these HIV variants may 
differ from common HIV isolates. However, the question of how HIV gains entry into renal epithelial 
cells remains unresolved. Evidence of direct infection by HIV of mesangial or renal endothelial cells 
also remains inconclusive. 
Role of HIV-1 Infection of Renal Epithelial Cells 
 In 1989 Cohen et al reported detection of HIV-1 in renal epithelial cells by DNA in situ 
hybridization. Other investigators reported detecting HIV-1 by PCR in tubules micro dissected from 
HIVAN biopsies specimens. Studies using an HIV-1 transgenic mouse model of HIVAN have 
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provided important insight into HIVAN pathogenesis. Mice transgenic for a replication-defective 
HIV-1 construct lacking the gag and pol genes, expressed under control of the viral promoter (long 
terminal repeat or LTR), develop proteinuria, renal failure, and histologic renal disease identical to 
HIVAN. 
 Bruggeman et al later demonstrated that the HIV-1 transgene is expressed in renal glomerular 
and tubular epithelial cells and that transgene expression in renal epithelial cells was required for the 
development of the HIVAN phenotype. The mechanism role of direct infection of renal parenchymal 
cells in HIVAN pathogenesis was provided by a macaque model of HIV-induced renal disease. 
Stephens et al  reported that passage of a chimeric simian-human immunodeficiency virus (SHIV) 
containing sequence from HIV-1 and the simian immunodeficiency virus (SIV) was capable of 
causing severe glomerulosclerosis and tubular disease  and  differences in viral strains mediated renal 
pathogenesis.. 
 In 2000 Bruggeman et al. reported a series of 20 HIV-1–seropositive patients with renal 
disease who underwent renal biopsies. All but one of the patients was black or Hispanic, and 15 had 
HIVAN. In 11 of 15 patients with HIVAN, HIV-1 was detectable in renal epithelial cells by RNA in 
situ hybridization. In several samples, the presence of HIV-1 was confirmed using riboprobes specific 
for both the nef and gag genes and by DNA in situ hybridization. HIV-1 RNA was detected in renal 
tubular epithelial cells, glomerular visceral and parietal epithelial cells, and interstitial leukocytes. The 
pattern of HIV-1 infection of renal tubules is focal and may involve epithelial cells from multiple 
nephron segments, including proximal tubule, thick ascending loop of Henle, and collecting duct. The 





Kidney as a Reservoir for HIV-1   
 Infection of renal epithelial cells by HIV-1 has important implications for HIV-1 seropositive 
patients not only because it contributes to renal disease but also because the kidney may be an 
important reservoir for HIV-1. Bruggeman et al detected HIV-1 by both RNA in situ hybridization and 
DNA in situ PCR in three patients who had undetectable viral loads in peripheral blood sample .He 
also published a study in which biopsy specimens were collected prospectively from 21 HIV-positive 
patients with renal disease including HIVAN (N16) and other renal diseases (N5). The   investigators 
used several techniques, RNA in situ hybridization, and DNA in situ polymerase chain reaction to 
detect HIV nucleic acid in renal biopsy specimens. They detected HIV infection of renal epithelial 
cells, including podocytes, glomerular parietal epithelial cells, and tubular cells, in the majority of 
biopsy samples .HIV was detected in kidney specimens from patients with HIVAN and other forms of 
renal disease and further studies have shown that HIV infection and tubular microcystic dilatation 
occur in a focal distribution that can affect all nephron segments and renal tubular infection.  
  These findings were confirmed recently and extended by Tanji et al, who reported that in 
addition to renal epithelial cells, HIV-infected macrophages and T cells are present in the renal 
interstitium. No studies have definitely shown infection of nonepithelial renal parenchymal cells in 
vivo. Interestingly, in the series from Bruggeman et al, HIV-1 RNA was detected in each of the 4 
patients who had no detectable viral RNA in the plasma, suggesting that HIV can remain 
transcriptionally active in renal epithelial cells even in the presence of maximal viral suppression with 
antiretroviral therapy (ART). Moreover, Winston et al reported a patient who developed HIVAN in the 
setting of acute HIV-1 seroconversion. Proteinuria, renal failure, and histologic abnormalities 
improved dramatically after treatment with HAART. Despite an undetectable viral load in the 
peripheral blood while on HAART, the patient continued to express HIV-1 in renal epithelial cells as 
determined by RNA in situ hybridization. Thus, even in the face of an optimal virologic response to 
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antiretroviral therapy and clinical remission of HIVAN, HIV-1 infection persisted in the renal 
epithelium and the virus remained transcriptionally active at a low level.   
 Marras et al isolated HIV-infected renal tubules from two patients with HIVAN using laser 
capture microdissection to characterize the HIV-1 quasi-species present in the renal tubular epithelium. 
HIV-1 envelope sequences were amplified from isolated tubules by PCR and sequenced. Phylogenetic 
analyses were performed on envelope sequences from renal tubular epithelial cells and peripheral 
blood mononuclear cells (PBMC) from the same patient. In each patient, there was variation in the 
HIV-1 envelope sequences present in the renal epithelium.  
As viral replication is required for viral evolution and sequence variation, this study provided 
direct evidence that the HIV-infected tubular epithelium in HIVAN is capable of supporting viral 
replication. Moreover, the quasi-species of HIV-1 present in renal epithelial cells clustered separately 
from sequences derived from the same patients’ PBMC, indicating that HIV-1 infection of tubular 
epithelial cells represents a viral compartment that is separate from the blood.  
Thus, the renal tubular epithelium is a reservoir for actively replicating HIV-1 and may support 
evolution of viral strains that differ significantly from virus present in a patient’s blood. It is not 
known whether the renal epithelial compartment is more likely to harbor drug-resistant HIV-1 strains 
or whether the renal epithelium is susceptible to currently available antiretroviral drugs.  
These studies resulted in two major findings. First, there was divergence in the gp120 
sequences cloned from the renal epithelial cells, indicating that these cells are able to support full viral 
replication (which had not been shown previously). Second, phylogenetic analysis revealed that the 
gp120 sequences from kidney clustered separately within the radiation of gp120 sequences from the 
same patients peripheral blood mononuclear cells. These data suggest that the renal epithelium is a 
reservoir for HIV-1 that is not in equilibrium with the blood compartment. Whether this renal reservoir 
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contributes to rebound of plasma viral loads in patients who had previously been well controlled is 
unknown. 
HIVAN is caused by HIV Infection of Renal Epithelial Cells 
 Studies using transgenic animal models have been invaluable for determining the viral and 
patient-related factors that contribute to the pathogenesis of HIVAN. In the most extensively used 
transgenic model, known as Tg26, mice are transgenic for an HIV provirus with deletions of the gag 
and pol genes that is expressed under control of the endogenous viral long terminal repeat (LTR) 
promoter. Tg26 mice develop a clinical and histopathologic syndrome that is identical to HIVAN.  
Gharavi et al used genome-wide linkage analysis to identify genetic loci that are associated 
with a risk for developing the HIVAN phenotype, although the culprit genes have not yet been 
identified. Investigators have used the Tg26 model to determine whether the HIVAN phenotype is a 
result of renal expression of HIV-1 genes or, alternatively, the effect of systemic factors on the kidney. 
In reciprocal transplantation studies, kidneys from Tg26 mice that were transplanted into wild-type 
mice developed the HIVAN phenotype whereas wild-type kidneys transplanted into Tg26 mice 
remained normal, thereby showing that renal expression of HIV genes is necessary to produce the 
HIVAN phenotype. Expression of HIV-1 genes in vitro is able to recapitulate many of the cellular 
abnormalities associated with HIVAN in vivo. 
 One of the histopathologic hallmarks of HIVAN is the presence of podocyte proliferation. 
Normal podocytes are terminally differentiated quiescent cells and in most forms of chronic renal 
disease the number of podocytes decreases. In HIVAN, however, podocytes proliferate and undergo 
dedifferentiation with loss of expression of podocyte-specific markers including CALLA, 
synaptopodin, WT-1, and podocalyxin. Schwartz et al  showed that podocytes isolated  from Tg26 
mice have increased levels of proliferation and express lower levels of podocyte markers than 
podocytes isolated from wild-type mice. Furthermore, infection of wild-type podocytes with HIV-1 
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induces these same changes in vitro. The availability of transgenic models and in vitro cell-based 
assays that reliably model the in vivo histopathologic features of HIVAN have allowed investigators to 
identify viral and host factors that are critical for HIVAN pathogenesis.  
Viral Factors  The Tg26 mouse model, which recapitulates the full HIVAN phenotype, lacks the gag 
and pol genes, making it unlikely that expression of either of these genes is necessary for HIVAN 
pathogenesis. Zhong et al created several murine transgenic lines that expressed all HIV genes except 
gag, pol, and env under control of the nephrin promoter, thereby ensuring podocyte-specific gene 
expression. Most of these mice developed proteinuria and the typical glomerular and tubular changes 
of HIVAN. The renal phenotype in these mice also was dependent on the genetic strain of the mice, 
with a severe phenotype noted in FVB/N mice (same strain as Tg26) and minimal disease in C57BL/6 
mice. This study suggests that expression of vif, vpu, vpr, tat, rev, and/or nef in podocytes is sufficient 
to induce the HIVAN phenotype.  
NEF 
 Nef is a 206-amino acid protein with many reported functions.1) reduction of CD4 trafficking 
to the cell surface 2) effects on cytokine expression, and 3) prevention of apoptosis. Hanna et al 
created transgenic mice that express nef under the control of the human CD4 promoter, developed 
several features of acquired immune deficiency syndrome– like illness (loss of CD4 cells, wasting, and 
so forth) and interstitial nephritis. nef with a mutated SH3 binding not developed the wasting disease 
or  renal disease.  
Hussein et al found that mutation of nef completely eliminated podocyte proliferation and that 
infection of podocytes with a vector expressing nef alone induced podocyte proliferation and 
dedifferentiation. He showed that nef induced proliferation, and dedifferentiation of murine podocytes 
is mediated via Src kinase activation, with subsequent phosphorylation and activation of signal 
transducer and activator of transcription (STAT3) and mitogen-activated protein kinase (MAPK) Tg26 
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mice. In the study by Hussein et al podocytes that expressed nef showed loss of expression of the 
podocyte differentiation markers WT1 and synaptopodin, and had increased expression of the 
proliferation marker Ki-67.  
VPR Vpr is a 96–amino acid protein whose actions include facilitating nuclear import of the HIV 
preintegration complex and transactivation of the viral LTR promoter. Dickie et al, who created HIV 
transgenic mice vpr gene developed proteinuria and glomerulosclerosis, transgenic mice expressing tat 
and vpr under the control of the LTR promoter significant proteinuria and glomerulosclerosis, other 
HIV genes worsen the course of vpr-induced renal disease. The gene vpr was expressed under control 
of the c-fms (macrophage-specific) promoter also developed modest proteinuria and 
glomerulosclerosis. The mechanism of renal pathogenesis in these mice is unclear, however, because 
free Vpr protein can directly transduce cells, it is possible that macrophage-derived Vpr was taken up 
by renal epithelial cells, resulting in the renal phenotype.  
 Studies in nonrenal cells have shown that vpr can induce several cellular effects, including 
G2/M cell-cycle arrest and apoptosis. Rosenstiel et al showed that vpr expression in the HK-2 human 
proximal tubular epithelial cell line impaired cytokinesis and induced accumulation of multinucleated 
cells, RTEC in Tg26 mice and human HIVAN biopsies had increased levels of epithelial cell 
hypertrophy and multinucleation. These findings suggest that the in vitro abnormalities observed in 
vpr-expressing HK-2 cells also are present in HIVAN, provide insight into the mechanism of 
tubulointerstitial disease in HIVAN. 
TAT and ENV 
Tat is a 101–amino acid protein critical activator of HIV transcription and can induce cellular 
changes including cytokine production and apoptosis. Conaldi et al reported Tat protein induces dose 
dependent proliferation and loss of differentiation markers in vitro.HIV-1 env gene encodes the gp160 
protein, which after cleavage yields the gp120 and gp41 proteins. Gp120 is present on the surface of 
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HIV virions and facilitates infection of target cells by interacting with CD4 and a co-receptor. Gp120 
can induce aberrant proliferation and apoptosis of human mesangial cells40 and apoptosis of both 
tubular and glomerular epithelial cells...as mentioned above, podocytes are infected by HIV-1 in 
HIVAN. This infection induces several abnormalities, including increased proliferation and decreased 
expression of markers of differentiation, including synaptopodin, WT-1, GLEPP-1, and podocalyxin. 
 Similar alterations in podocyte phenotype are found in the glomeruli of HIV-1 transgenic mice. 
In vitro studies using podocytes from HIV-1 transgenic mice and wild-type murine podocytes infected 
with HIV-1 have demonstrated increased levels of proliferation and anchorage-independent growth in 
podocytes expressing HIV-1. Phenotypic abnormalities of the tubular epithelium are also prominent 
with increased proliferation and apoptosis, microcystic dilatation, flattening and atrophy of epithelial 
cells, and loss of expression of differentiation markers, with abnormal polarization of the sodium-
potassium ATPase. 
  Transcriptional regulation of HIV-1 in renal epithelial cells appears to occur via similar 
mechanisms as in lymphocytes. Transcription in murine podocytes requires binding of inducible 
nuclear factor-ƒEB and Sp1 to the viral LTR. Inhibition of HIV-1 transcription in murine podocytes 
using an inhibitor of CDK-9 resulted in decreased proliferation and re-expression of podocyte 
differentiation markers in vitro. Systemic administration of these CDK-9 inhibitors to HIV-1 
transgenic mice ameliorated the HIVAN phenotype. Given the markedly decreased efficiency of HIV-
1 transcription in murine cells, however, it is unclear whether CDK-9 inhibition would have similar 
effects in podocytes from humans with HIVAN. 
Factors Promoting Apoptosis and Fibrogenesis 
          Increased apoptosis of tubular epithelial cells and interstitial fibrosis are common findings in 
many nephropathies, including HIVAN. Bodi et al compared biopsy specimens from patients with 
HIVAN with HIV-seronegative patients with focal segmental glomerulosclerosis and found a 
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substantially higher rate of tubular epithelial apoptosis. Conaldi et al showed the ability of HIV-1 to 
infect human tubular cells and induce apoptosis in vitro. HIV infection induced extensive caspase-
dependent apoptosis of proximal tubular cells and, in further experiments; the investigators found that 
the apoptosis-inducing receptor, Fas was up-regulated by HIV infection. The importance of Fas up-
regulation in HIV-induced tubular cell apoptosis was not clear because addition of Fas-blocking 
antibodies to the cells did not prevent apoptosis. 
Ross et al reported that the ubiquitin-like protein FAT10 is one of the most up-regulated genes 
after HIV infection in a RTEC line derived from a patient with HIVAN. Expression of FAT10 also 
was increased in kidneys from Tg26 mice and in HIVAN biopsy specimens, and prevention of FAT10 
expression using RNA interference prevented HIV-induced apoptosis. Although these results suggest 
that FAT10 expression is necessary for HIV-induced RTEC apoptosis, the mechanism by which 
FAT10 facilitates apoptosis is not known 
Transforming growth factor (TGF)-is a cytokine with important roles in promoting renal fibro 
genesis and apoptosis in several animal models of renal disease. Increased levels of TGF mRNA when 
compared with biopsy specimens of HIV-positive patients without signs of HIVAN and TGF-protein 
levels are increased in HIV positive patients with glomerular disease. 
Inflammatory Mediators 
 Tubulointerstitial inflammation is a prominent histopathologic finding in HIVAN. 
Accordingly, several case series and retrospective case-control studies have reported an association 
between corticosteroid treatment and improved renal outcomes in patients of HIVAN. These 
observations suggest that renal inflammation is an important factor in the clinical course of HIVAN. 
Ross et al profiled the genes that were differentially expressed after infection of a human RTEC line 
derived from a patient with HIVAN. The most prominent response of the cells to HIV infection was 
up-regulation of proinflammatory mediators, including cytokines, chemokines, and adhesion 
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molecules. Many of these same genes were found to be up-regulated markedly in kidneys from the 
Tg26 HIVAN model. The expression of HIV genes in RTEC up-regulates proinflammatory genes that 
then recruit leukocytes to the kidney, resulting in the tubulointerstitial inflammation that is a 
characteristic finding in HIVAN.  
 Several cytokines, including interleukin-8, monocyte chemoattractant protein-1, and RANTES, 
were increased in HIV-infected patients. Patients with HIVAN were found to have higher renal tissue 
levels of major HLA class II, interferon-receptor, and interferon-alfa, although levels did not correlate 
with the amount of interstitial inflammatory cells. These studies suggest that HIV-infected patients 
have increased renal levels of inflammatory mediators, which can recruit inflammatory cells into the 
interstitium. 
Proliferation 
As discussed previously, the HIV-1 nef gene induces podocyte proliferation via activation of 
Src kinases and the transcription factors Stat3 and MAPK. Dysregulated expression of cyclins is also 
an important factor in promoting podocyte proliferation in HIVAN. HIV infection increases cyclin E 
expression in podocytes. The expression of the cyclin-dependent kinase (CDK) inhibitors p27 and p57 
are decreased in HIVAN biopsy samples as compared with normal kidneys or those with membranous 
and minimal change disease, whereas p21 levels are increased. Because CDK inhibitors suppress the 
activity of pro-proliferative cyclin/CDK complexes, the increased levels of cyclin E, coupled with 
decreased p27 and p57, likely contribute to podocyte proliferation in HIVAN.  
 Basic fibroblast growth factor is upregulated in HIVAN and has been shown previously to 
increase proliferation of renal epithelial cells in vitro.HIVAN is also associated with the up regulation 
of tansforminrg growth factor-ƒÀ, which may in part, mediate increased renal fibrosis and apoptosis. 
we identified a novel small leucine-rich repeat protein, Podocan, which accumulates in sclerotic 
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glomeruli in HIV-1 transgenic mice. The role of Podocan in HIVAN pathogenesis is currently under 
study. 
Mediators of Cell Adhesion, Cell Signaling, and Extracellular Matrix 
 Kaufman et al reported that the sidekick-1(sdk-1) gene is up-regulated in HIV-infected 
podocytes and levels of Sdk-1 protein are increased in vivo in podocytes in the Tg26 mouse model 
Sidekick proteins are members of the immunoglobulin super family and have roles in neuronal 
guidance during retinal development. HIV-induced expression of SDK-1 leads to aggregation of 
podocytes in vitro and may contribute to the formation of podocyte “pseudocrescents” that are 
observed commonly in HIVAN.  
 Altered expression of vascular endothelial growth factor (VEGF) contributes to the 
pathogenesis of many renal diseases. In mice, increased expression of the VEGF 164 isoform induces 
a collapsing glomerulopathy similar to that found in HIVAN. Korgaonkar et al detected increased 
levels of VEGF protein and its transcriptional regulator (HIF-2) in glomeruli in the murine HIVAN 
model and in human HIVAN biopsy specimens. Infection of murine podocytes with HIV in vitro 
induced expression of VEGF and HIF-2, which was mediated via nef-induced activation of Src kinase 
and Stat3. Moreover, addition of neutralizing antibodies against VEGFR2 reduced HIV-induced 
podocyte proliferation and dedifferentiation in vitro. These studies suggest an important role for 
VEGF in HIVAN pathogenesis. 
CLINICAL PROFILE OF RENAL LESIONS IN HIV 
Acute Renal Failure 
I. Epidemiology and Etiology 
Consensus guideline for management recommend a definition of acute renal failure in HIV 
patients who has  increase in serum creatinine of above 1.5mg/dl or increase of greater than 1.3 times 
 20 
normal at the respective laboratory, that returns to base line value within 3 months. The causes of AKI 
in HIV classified as pre renal, intrinsic renal and post renal acute renal injuries. 
a). Pre Renal causes 
 The most common cause is hypovolemia:  The causes of hypovolemia in HIV patients include 
diarrhea, nausea, vomiting, and decreased oral intake. Hypovolemia also results from decrease in 
effective circulatory volume in few clinical situations such as sepsis, liver disease, and 
hypoalbuminemia (nephrotic syndrome, proteinuria,malnutrition). 
b). Intrinsic Renal Injury causes  
        Acute Tubular Necrosis 
        Ischemic: Hypovolemia, Shock, Sepsis, Cardiopulmonary compromise 
        Nephrotoxic: Medications, Radiocontrast,  Rhabdomyolysis 
                             Parenchymal infection ( bacterial, fungal and viral) 
        Interstitial Nephritis 
        Hemolytic Uremic Syndrome 
        Glomerular disease 
         HIVAN,  Acute Glomerulonephritis, 
         DILS (diffuse infiltrative lymphocytosis syndrome)  
c). Post Renal causes 
       Intrarenal Tubular Obstruction:  
       Crystalluria    from medications, Tumor Lysis  Syndrome 
       Ureter or Bladder Obstruction: 
       Nephrolithiasis, 
       Lymphadenopathy/Tumor, Fungus ball, Blood clots,  
       Neurogenic Bladder 
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d). Risk Factors for AKI in HIV 
This include  old age,  Diabetes mellitus, Chronic kidney disease, Liver disease/Hepatitis C,  
low CD4 count, high HIV-RNA level, history of AIDS-defining illness, history of Antiretroviral 
exposure, Immune Reconstitution Syndrome, Drugs etc. 
In the pre ART era study by Valeri et al 1991 reported in a study of 1983-1986 ARF with 
serum creatinine of >2mgin 20% of 449 hospitalised HIV patients, and found the incidence in non 
HIV patients of 4-5%. In this series common causes of ARF include were hypovolemia (38%) 
medication toxicity(32%), ATN in 26%(ischemic,toxic,rhabdomyolysis) 2%with AIN, 17%of  
obstruction due to drug induced, paraprotein precipitation and 35% due to HUS. In a retrospective 
review of all cases for AKI with Serum creatinine of >6mg/dl one third occurred in HIV, from  New 
York between 1984 and 1993 by Rao et al, here 52% were  caused by ischemic insult, 23% due to 
nephrotoxic medications (aminoglycosides, amphotericin B, pentamidine, acyclovir, AIN due to 
NSAIDs) and rhabdomyolysis. 
AKI in HIV is more likely due to sepsis and less likely due to obstructions.  In 2006 Wyatt 
reported AKI in 1995 in hospitalized patients of 2.9% among 52580  HIV patients compared to 1% of 
non HIV during the same year  which include both ART and non ART HIV patients. As per the New 
York state planning and research cooperative system data base with decrease in infections and 
mortality and   increase in non HIV comorbidities, the incidence of AKI during 2003 was 6%  higher  
than for HIV negative of 2.7%, and the  increase in incidence could be due to changes in reporting in 
the ART era. 
Franceschini  (2005) reported 2yrs  follow up of 754 HIV patients;   incidence of AKI was 5.9 
cases per 100 patient years, with at least one episode in 10% of patients. Intrinsic renal lesions were in 
46%, prerenal in  38%, and 52% were associated with infections, and medications in one third.Rao et 
al in 2005 reported nephrotoxic drugs were common cause of AKI in a cohort of 2274 patients and 
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nearly 6% of them experienced at least one episode of AKI during the study period. Although direct 
infection of kidney by HIV is a cause of AKI and HIVAN is a recognized entity, rare cases of  
parenchymal infection include fungal infections, Mycobacterial granulomatous infection, interstitial 
nephritis secondary to Ebstein Barr virus, Cytomegalo Virus, Polyoma virus and other viruses. 
Another rare cause of AKI is due to immune inflammation syndrome that typically occurs after 
initiation of ART is a systemic inflammatory response to infections or noninfectious diseases and 
kidney biopsy may show granulomatous nephritis. Rhabdomyolysis occurs particularly in association 
with cocaine, statins and in acute in HIV infections has been reported frequently.    
e). Nephropathy associated with Diffuse Infiltrative Lymphocytosis Syndrome (DILS) 
            Most patients are adults who have been infected for years from both sexes, of all ethnic groups, 
present with bilateral parotid enlargement and sicca syndrome for months ,respiratory, liver, renal 
lesions are rarely associated features. The disease is due to persistant CD 8 + lymphocytic infiltration 
of multiple organs mainly salivary gland and occasionally lungs, muscles, peripheral nerves, gastro 
intestinal tract liver and kidneys. Scant literature is only available and the renal syndrome is poorly 
described. Renal syndrome is typically present with large kidneys, tubulointerstitial disease, mild 
grade proteinuria composed of tubular proteins. 
 On renal biopsy it is characterized by acute tubulo interstitial nephritis, with patchy to dense 
interstitial cellular infiltrate composed of lymphocytes, monocytes and plasma cells. Zafrani et al 
reported in 2007 of 111pts with DILS 9% incidence of renal lesions were described. This CD8 
lymphocytosis is considered to be due to HIV infection, and the recent reports indicate there are 
decreased incidences of DILS due to HAART. Treatment with short course of steroid helps to 




f). Acute Renal Failure due to Medications  
 Most of the renal toxicities are type B adverse drug reactions. In contrast to the more common 
type A adverse drug reactions, type B adverse reactions are generally idiosyncratic, not dose 
dependent, and have less pharmacologic predictability because they are mostly driven by 
uncharacterized host factors. Established renal adverse reactions have been associated with the use of 
several Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Protease Inhibitors (PIs). Because 
renal transporter–mediated mechanisms are involved in the elimination of these agents, intracellular 
accumulation and potential toxicities may occur if these mechanisms are perturbed. 
 Organic anion transporters (OATs) and organic cation transporters are expressed on the 
basolateral membrane of proximal tubular cells and mediate the uptake of NRTIs and PIs. Multidrug-
resistant proteins and P-glycoproteins are expressed on the apical membrane of proximal tubular cells 
and mediate the efflux of these agents. Disruption in basolateral uptake, apical efflux, results in 
accumulation of these agents in the proximal tubular cells with potential drug toxicity. 
1). Nucleoside Reverse Transcriptase Inhibitor (NRTI) related Nephrotoxicity  
NRTIs generally require dose adjustment in patients with kidney disease, the one exception 
being abacavir sulfate .Adverse effects of ART have been well recognised, including metabolic, lipid, 
and bone toxicities. Importantly, renal toxicity has been associated with several of these agents. NRTIs 
are processed and eliminated by the kidney. The OATs have been postulated to constitute the initial 
step in the uptake of several NRTIs. 
Hyperlactatemia is a relatively frequent adverse event associated with the use of NRTIs. It can 
be detected in up to 20% to 30% of patients treated with NRTIs, typically after several months of 
therapy. Most of the time  lactate increases were small in magnitude (lacticacid>2.5 mmol/L), often 
transient, and not associated with identifiable symptoms.Severe hyperlactatemia (lactic acid,5-10 
mmol/L) can occur in up to 1.5% to 2.5% of patients and is associated with a mortality rate of more 
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than  50%. Stavudine is one of the implicated NRTIs, although all agents in this class have been linked 
with hyperlactatemia.  
 Among NRTIs currently approved for the treatment of HIV-1, renal toxicity has been most 
clearly established with tenofovir. Renal toxicity also is well-described with 2 NRTIs that are related 
structurally to tenofovir , they are cidofovir, which is FDA-approved for the treatment of 
cytomegalovirus retinitis in HIV-1–infected individuals, and adefovir. Tenofovir has been associated 
with renal tubular toxicity resulting in acute tubular injury, Fanconi syndrome, nephrogenic diabetes 
insipidus, and acute or chronic reduction in glomerular filtration rate. 
 Mitochondrial DNA depletion owing to inhibition of DNA polymerase, the major enzyme 
responsible for replication of mitochondrial DNA, has been proposed as a mechanism of systemic and 
renal toxicity of NRTIs retrospective analysis of a large observational cohort of patients who received 
either tenofovir  or an alternative NRTI showed that the use of tenofovir was associated with a greater 
decline in renal function compared with the use of other NRTIs, although the clinical significance was 
unclear. Study in 2007 by Amanda et al published largest study that assessed GFR in HIV infected 
persons, patients treated with tenofovir, and in indinavir had increased odds of CRF .At the time of 
first serum creatinine measurement within Eurosida study in a study from US 7.2% of found to have 
renal disease at basal line with 14% subsequently developing renal sufficiency after a mean period of 
21 months. 
2). NNRTI Nephrotoxicity 
Rhabdomyolysis with acute renal failure was described in a single case owing to potential 
interaction of delavirdine mesylate, with atorvastatin. Nevirapine has been implicated in the 
development of acute renal failure with rash and eosinophilia in a pregnant patient. Efavirenz has been 
recently linked to nephrolithiasis in 2 patients. Acute renal failure has been reported to occur in 1% of 
patients assigned to etravirine in clinical trials. 
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3). Protease Inhibitor Nephrotoxicity 
The use of indinavir sulfate and atazanavir sulfate has been linked to nephrolithiasis, the 
former to a much greater degree. Ritonavir has been implicated as a cause of acute renal failure in 
several reports.The incidence of symptomatic crystalluria or nephrolithiasis has been estimated at 8% 
to 19% of patients on chronic therapy. The  prevalence of atazanavir stones to be 0.97% among those 
taking the drug.   
4). Entry Inhibitor -HIV-1 Fusion Inhibitor Nephrotoxicity 
  Enfuvirtide safety analysis of the TORO 1 and TORO 2 trials, including 663 patients  reported   
one patient  with  hypersensitivity reaction with a membrano  proliferative nephritis. 
5). Integrase Inhibitor Induced nephrotoxicity 
Placebo controlled trials in treatment-experienced HIV- 1–infected patients receiving 
Raltegravir 600 mg daily, and also with 400 mg twice daily in combination with optimized 
background therapy revealed a  high incidence of vomiting and diarrhea associated prerenal azotemia.. 
Fluid and Electrolyte disorders  
 This involves important electrolyte disorders  occurring  either at initial presentation or during 
the management of patient with HIV. Most commonly reported electrolyte abnormalities are 
hyponatremia, hypokalemia, and  hyperkalemia . Magnesium deficiency also reported in patients with 
chronic diarrheal illnesses. 
a). Hypotrnatremia   
 Hyponatremia is frequent among HIV infected persons with a reported prevalence of 30 to 
60% of hospitalized patients, it is a marker of severe illness and associated with increased mortality. In 
a study of 212 HIV patients the mortality of hyponatremic group was 36.5% compared to 19.7 of 
normonatremic group. 
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                 The etiology and management of hyponatremia differ according to the time of its 
presentation. Volume depletion caused by vomiting, diarrhea are the common cause of hyponatremia 
at the time of hospital admission. In contrast, syndrome of SIADH is the likely culprit among patients 
during hospitatisation. SIADH is associated with common pulmonary and intracranial infections such 
as pneumocystis jiroveci, toxoplasmosis, and tuberculosis and malignancies. 
b). Potassium disorders 
   Both hypokalemia and hyperkalemia are common among HIV patients. Hypokalemia is seen 
commonly in patients with gastro intestinal infections which leads to vomiting and diarrhea, and in  
patients receiving amphotericin B commonly used to treat fungal infections, which cause tubular 
dysfunction and lead to severe hypokalemia. Tenofovir has also associated with proximal tubule 
dysfunction and life threatening hypokalemia. 
 Drug induced hyperkalemia include high dose trimethoprim suphamethoxazole  and 
intravenous pentamidine, similar to amiloride. These drugs inhibit sodium transport leading  to 
decrease in  potassium secretion  in the distal nephron. Also actue and chronic kidney disease  may 
contribute to hyperkalemia. Hyperkalemia may be a manifestation of mineralocorticoid deficiency 
resulting from adrenal deficiency or syndrome of hyporeninemic hypoaldostrenism.  
c). Acid- base balance    
 They are caused  by infections and drugs. Respiratory alkalosis and respiratory acidosis may 
occur in opportunistic infections of the lungs or nervous system. Non anion gap metabolic acidosis 
occurs due to many causes which includes intestinal losses of bases caused by diarrhea and renal 
acidosis resulting from adrenal insuffiency, syndrome of hyporeninemic hypoaldosteronism, or drug 
toxicity (amphotericin B). High gap acidosis results from chronic kidney disease, Type A lactic 
acidosis caused by tissue hypoxia, and Type B lactic acidosis presented with markedly elevated blood 
lactate levels caused by drug induced mitochondrial dysfunction due to NRTI such as zidovudine, 
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lamivudine, stauvudine, didanosine , zalcitabine etc. Although life threatening acidocis is rare, 5-25% 
of treated patients may develop mildly elevated lactate levels of 2.5-5mmol/l. Routine lactate 
measurement in patients with low bicarbonate, elevated anion gap and abnormal anion gap is 
necessary for managing these groups of patients. 
Chronic kidney Disease 
   Anatomical, biochemical, radiological and functional abnormalities of kidney disease of more 
than three months are included in this group of patients.  This large group of patients with chronic 
lesions includes HIV associated nephropathy (HIVAN), HIV related immune complex Glomerulo 
nephritis. Hemolytic Uremic Syndrome, Chronic Interstitial Disorders due to the HIV viral infection 
and  drugs used to treat the virus and other related complications. 
 HIV Associated Nephropathy (HIVAN) 
In 1984 series of patients with advanced AIDS and rapidly progressive renal failure (RPRF) 
were reported from New York. All of then were African Americans or Haitian immigrants. Early in 
HIV epidemic the clinical presentation of proteinuria and RPRF was seen in 10% of cases in US. The 
classical presentation of HIVAN is characterized by RPRF, non hypertensive and without significant 
peripheral edema moderate to nephrotic proteinuria, bland urine sediment and ultra sonogram findings 
of large highly echo genic kidneys and most have CD4 count below 200/cmm and progressing to end-
stage renal disease within 8–16 weeks.. Progression to death or ESRD was universal and become the 
third leading cause of ESRD among African Americans occurring between ages of 20 to 64 yrs. Since 
the introduction of HAART the incidence of death due to HIV in all ethnic groups including African 
Americans, and the number of new cases decreased after 1996, however the rate of decline in 
incidence of ESRD due to AIDS nephropathy has slowed and the number of new cases actually 
increased in 1999 (USRDS). 
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Renal Pathology of HIVAN 
         Light Microscopy  
Glomeruli 
              Untreated HIVAN typically manifests as collapsing pattern of FSGS. Capillary lumina are 
occluded by implosive wrinkling and collapse of the glomerular basement membrane that is more 
often global than segmental .In this acute injury there is lack of appreciable increase in intracapillary 
or mesangial matrix. The collapsing FSGS is accompanied by prominent hypertrophy and hyperplasia 
of overlying podocytes, which have enlarged open vesicular nuclei and with frequent nucleoli, 
occasional binuleate forms and rare mitosis features. The visceral epithelial cells may be so crowded 
as to obliterate the urinary space forming pseudocrescents. The podocye cytoplasm is typically 
vacuolated: contain prominent intracytoplasmic protein resorption hyaline droplets. As the lesions 
evolve tuft retracts into a solidified ball crowned by overlying enlarged vacuolated visceral epithelial 
cells, and the urinary space appears dilated and contains  proteinaceous filtrate. However repeat 
biopsies and postmortem studies have shown collapsing lesions may evolve into a more typical pattern 
of FSGS (NOS). 
Tubulo Interstitium 
              Invariable component of HIVAN; lesions are out of proportion to the glomerular injury  .In 
addition to tubular atrophy, interstitial fibrosis, edema and inflammation, there are widespread tubular 
degenerative and regenerative changes. They include tubular epithelial simplification, and hypertrophy 
with enlarged hyperchromatic nuclei, prominent nucleoli, mitotic figures and focal apoptosis. 
Distended tubules contain loose proteinaceous casts. Tubular micro cysts are seen which may be 
numerous. Interstitial leucocytes, predominantly of lymphocytes are present  with CD4/CD8 ratios  




              Segmental  deposits of IgM , C3, and less commonly C1 in the collapsing segments. The non 
collapsed glomeruli may show weaker mesangial staining for IgM and C3. podocytes resorption 
droplets often stain for IgG, IgA, and albumin and similar findings in tubular epithelial protein 
droplets. 
Electron   Microscopy 
          Collapsed lobules display wrinkling with little or no thickening of GBM, overlying  podocytes 
are markedly hypertrophic with severe foot process effacement, focal detachment, and increased 
numbers of electron dense protein resorptin droplets, electron lucent transport vehicles and abundant 
rough endoplasmic reticulum. Actin cytoskeleton is distrupted giving the cells a relatively open 
appearing cytoplasm. Noncollapsed glomeruli also show severe foot process effacement, typically 
greater than 50% of capillary surface area and often more than 90%. 
           Endothelial tubulo reticular inclusions also known as interferon foot prints, identified as 24nm 
tubular structures located in the dilated  cisternae of smooth endoplasmic reticulum: they are not 
specific for HIV and also seen in SLE, Hepatitis C and other viral infections.and interferon therapy but 
lacking in pamidronate toxicity and parvovirus B19 infections. 
          Tubular cells show enlarged regenerative nuclei with prominent nucleoli and the cells lining the 
tubular microcysts are typically flattened. And there are increased number of nuclear bodies within 
tubular and interstitial cells. 
Podocyte Dysregulation in HIVAN 
The injured podocyte in HIVAN recruits back to developmental programme. That includes 
down regulation of cell cycline kinase inhibitors,entry into cell cycle and loss of maturation phenotype 
markers. It involves loss of podocyte expression of WT1 and the podocyte is called dysregulated 
injured podocyte.  It expresses proliferation markers Ki67, and loses  maturation markers  such as  
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CD10/CALLA,C3b receptor,GLEPP-,1 podocalyxin , synapotopodin and WT-1. Synaptopodin loss 
precedes collapse. There is decreased expression of P27 and P57and de novo expression of P21 and 
Ki-67 
Differential diagnosis  
 Biopsy picture also may be present in few other conditions  which include primary FSGS, 
parvo virus B19,  SV 40 infection, acute CMV infection, erythrophagocytosis syndrome, interferon 
therapy, pamidronate toxicitry, acute veno occlusive injury, familal forms and glomerular injury in 
renal allograft associated with microvascular disease. Increasing prevalence of FSGS NOS in parallel 
with reduction of HIVAN suggests modifications of collapsing pattern of HIVAN by ART are noted 
in the recent literature.  
Immune Complex Renal Disease and HIV Infection 
 HIV infection often leads to the development of polyclonal hypergammaglobulinemia, and 
circulating immune complexes frequently are found in HIV-infected patients. Kimmel et al showed 
that immune complex deposits, composed of HIV peptides and antibodies directed against these 
antigens, lead to the development of glomerulonephritis. Immune complex deposition may be related 
to an immunologic response to opportunistic infections that stems from the immunocompromised state 
and may represent a state of postinfectious glomerulonephritis. It also is possible that 
glomerulonephritis in the setting of HIV infection may be unrelated to the underlying viral infection, 
but rather shares the same pathogenic mechanisms as other glomerulonephritidesthat affect the general 
population.  
 One proposed mechanism for the development of glomerulonephritis in HIV-infected patients 
is passive trapping of immune complexes containing HIV antigens. In several well characterized 
patients, the association with HIV infection has been established with certainty by showing circulating    
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Or tissue   immune complexes consisting of HIV antigens, such as p24, gp41, and gp120, bound to 
IgG or IgA antibodies to these antigens. Alternatively, in situ immune complex formation, with 
circulating antibodies binding to HIV antigens deposited on glomerular cells, may play a causal role 
similar to the mechanism underlying other idiopathic glomerulonephritides. Research in HIV infected 
patients to date cannot discriminate whether passive trapping of immune complexes or in situ antibody 
deposition leads to the development of glomerulonephritis. Cellular immune responses likely play a 
synergistic role in the development of glomerulonephritis in HIV-infected patients. 
 The immune complex renal diseases associated with HIV includes, IgA nephropathy, 
membranoproliferative glomerulonephritis, postinfectious glomerulonephritis, membranous 
ephropathy,  Membrano proliferative glomerulonephritis, lupus like glomerulonephritis, 
cryoglobulinemic glomerulonephritis, immunotactoid glomerulopathy, and fibrillary 
glomerulonephritis  .  
 Hass et al reported the re view of renal biopsies from 1996  to 2003 in 77 specimens 14 had 
met the criteria of Lupus like features with full house immune complex staining from ≥1+,and the 
patients serum negative or weakly positive for ANA ≤1:80and negative for Anti Ds DNA.  
Thrombotic Micro Angiopathy (TMA) 
              Most of the literature belongs to the pre HAART era, the first described case 1984 by Boccia 
et al in with kaposis, who died of staphylococcal sepsis. Gadallah reported a 7% incidence multicente 
autopsy study of 214 patients, French study of 92 patients, 60 underwent renal biopsy and the TMA 
incidence was in 32 patients. TMA appears to occur in with untreated advanced infection indicated by 
low CD4 counts, though case reports also described as a first manifestation of HIV. Peraldi reported in 
1999 the largest series with with TMA, with low mean CD4 of 43cells /mm3 evidence for TMA was 
seen in 20 out of 26 biopsies, mean serum creatinine was 4.2mg, 12 of 26 had active CMV infection, 
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8% on one ART drug and 12% were on 3 drugs, the pathogenesis clearly involving endothelial cells 
and not different from the general population. 
Non HIV related diseases in HIV patients 
  The life expectancy of people with HIV increased dramatically after the introduction of highly 
active anti retroviral treatment (HAART). The incidence of diabetes mellitus is slowly increasing in 
HIV patients because of the life style and drugs  contributing to life expectancy. The life expectancy 
also increase the incidence of hypertension in HIV population along with other factors such as 
smoking, alcoholism, obesity,  hyperlipidemias. 
                          Hepatitis B, Hepatitis C, polyoma virus(BK), polyoma B19, and other  renal diseases 
as in general population includes primary and secondary glomerular lesions, interstitial lesions  and 
post renal disorders. The incidence of Hepatitis C infection is high in certain group of patients 
described in Middle East, Europe and United States. The incidence of Hepatitis C coinfection is varies 
from 10 to 30 % in few studies. 
Hepatitis C and HIV  
Approximately one third of HIV individuals are co infected with Hepatitis C with higher rates 
in patients infected parentally. A Varity of renal lesions associated with Hepatitis c include 
membranous, focal segmental glomerulosclerosis and membrano proliferative with or without 
cryoglobulinemia, these lesions observed in the co infection also. There are notable differences in co 
infected HIV –Hepatitis C patients. The degree of renal insufficiency was more advanced, lower 
prevalence of Hypocomplementemia, cryoglobulinemia compared to isolated Hepatitis C infection. 
Only 1% had organized deposits compared to Hepatitis c infection alone. Renal outcome is worse and 
the clinical course resembles more of HIVAN.  
In addition PIGN, fibrillary glomerulo nephritis, and immunotactoid glomerulopathy reported 
in this subset of HIV patients. 
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BK virus and HIV 80% of population is seropositive for BK virus, it establishes latent 
infection in renal tubular cells, and urinary tract epithelia, results in interstitial nephritis, hemorrhagic 
cystitis and urethral, ureteral stenosis in transplant population. Few isolated cases were in the 
literature, in one series 6 cases reported with HIV and BK virus nephropathy.  
End Stage Renal Disease 
 Though not much statistical evidence is available for the exact incidence of ESRD in HIV 
population, because of the high  incidence of HIVAN, HIV contributes to the third leading cause of 
ESRD among Afro Americans.  The USRDS reported  4219 ESRD  cases in HIV patients from year 
2000 to 2004. Almost 90% in African Americans. Early studies in 1980s reported most with ESRD die 
within 1-3 months of starting hemodialysis in the pre ART era, because they presented late in the 
disease with much advanced opportunistic infections. In year 1999 the 1 year survival rate of HIV is 
equivalent to the general population as per the US ESRD registry.(240 deaths vs. 236.4 per 1000 
patient years)  . Similar outcome was described in French dialysis and outcomes and practice pattern 
study II. Hemodialysis, peritoneal dialysis and renal transplantations are the accepted modes of 
management fore ESRD. Coinfection with HCV is common in HIV ESRD and the reported 
prevalence as high as 50% and the optimum therapy remains undetermined. Renal replacement 
therapy (RRT) in HIV- ESRD has improved the survival for the last two decades.  
Hemodialysis 
 It is the most common form of RRT for HIV patients. Strict adherence to general principles of 
prevention is absolutely necessary by the health care providers. Early surgical referral for 
arteriovenous fistula is necessary because of increased  incidence of infections and poor outcome of 
AV graft. Disadvantages include infections of temporary catheters and AV grafts, and risk to dialysis 
providers because of blood and needle stick exposures. Early referral for AV fistula preferred because 
of inferior outcome of AV grafts. Infection rate in synthetic grafts is 43% in AIDS, 36% with 
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asymptomatic HIV infection, and 15% in HIV negative patients. Thrombus free native graft survival 
was comparable to non HIV patients. 
Peritoneal Dialysis  
 Outcome between Hemodialysis and Peritoneal dialysis are equivalent. Peritoneal dialysis 
patients have benefit of preservation of residual renal function when compared to hemodialysis 
patients. Disadvantages include increased protein loss, increased incidence of peritonitis especially 
higher incidence of pseudomonas and fungal infections.  The risk to health provider is the persistence 
of the live virus in peritoneal fluid for over 7 days and in the tubings for over 48 hours and the spread 
of infection prevented by strict aseptic procedures, and use of sodium hypochlorite solution. 
Kidney transplantation  
 Roland et al in 2007 reported 94% 3 year survival in renal recipients but 12 of 18 experienced 
acute rejection episodes (67%), and the 3 year cumulative rejection episodes were 73%. Despite 
concern of immunosuppression required to prevent graft rejection might increase HIV disease 
progression has not been observed in renal transplant recipients. Cyclosporine, mycophenolate mofytil 
and sirolimus are immunesuppressive drugs with antiretroviral activity and they may counteract the 
theoretical risk of HIV progression. NIH sponsoring a study in 20 centres in US for transplants in 
HIV-ESRD patients with the following category with preliminary results support kidney 
transplantation is a viable option. They include CD4 ≥200cell for adults CD4 % of ≥ 30% for children 
1-2 years old, ≥ of 20% for  2-10years .and HIV RNA must be undetectable by ultrasensitive assay. 
National and International studies of Renal Lesions in HIV  
  In 2004, HIVAN was the seventh leading cause of ESRD in the African American population. 
In the UK, a study from the university College London Hospitals carried out between 1992 and 1996 
showed that 1% of patients with ESRD had HIV, that HIV-associated renal disease ranked 14th among 
the most common causes of ESRD. In Perald’s study of hospitalized patients with HIV, AKI occurred 
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in up to 20% of cases. Kimmel et al in another study of hospitalized patients with HIV and AKI had a 
mortality rate of 18% at 2 months, with 80% of patients diagnosed with AIDS at the time of hospital 
admission. Prospective study by Franceschini et al of patients with HIV and AKI concluded that 
severe immunosuppression (CD4+ t-cell count<200 cells/mm3 and/or HIV rna level >10,000 
copies/ml)is the predominant risk factor for AKI.  
            Screening studies performed across sub-Saharan Africa report widely different prevalence of 
kidney disease in HIV. In most of these studies kidney disease was defined as the presence of 
albuminuria and/or low estimated GFR (based on serum creatinine measurements). Reported 
prevalence ranges between 6% and 45%. this wide variation could be ascribed in part to differences in 
study design, populations studied (in terms of demographic characteristics and/or ethnic origin) and 
definitions of CKD used. Some studies measured proteinuria only by dipstick, whereas other studies 
quantified it and some studies might not have performed serum creatinine measurements. Very few 
studies described the histological pattern of kidney disease as revealed by kidney biopsy and fewer 
still described response to treatment. 
  Two screening studies have been performed in south Africa. The first study included 615 
ART-naïve out patients with HIV and found that 6% had persistent proteinuria. Renal biopsy samples 
were collected from 30 of the 37 patients with persistent proteinuria, and histology showed HIVAN to 
be the predominant condition (83.3%) with other conditions observed being HIVAN combined with 
membranous glomerulonephritis, membranoproliferative glomerulonephritis and interstitial nephritis. 
The second study, which included 578 ART-naïve outpatients, reported that persistent proteinuria was 
observed in 5.5% of patients and that 20 renal biopsies were performed. HIV-associated immune 
complex disease was seen in 40% of cases, HIVAN   5%, and a combination of HIVAN and immune 
complex disease in 5%. Furthermore, 45% of biopsy samples displayed mesangial and/or interstitial 
changes that did not meet the current histological criteria for HIVAN. 
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  In this study, initiation of ART resulted in a significant improvement in estimated GFR and a 
marked reduction or resolution of proteinuria, mostly within the first 6 months. Another study carried 
out in South Africa included 99 ART-naïve hospitalized patients and showed 27% had HIVAN, 21% 
had HIV-associated immune complex disease, and 13% membranous nephropathy, with the remainder 
of patients displaying the hallmarks of non glomerulonephritic renal disease, post infectious or 
mesangioproliferative glomerulo nephritis and IgA nephropathy. Evidently the histological patterns of 
renal disease in patients with HIV are variable, even within the same region. This observation might 
reflect the high degree of genetic variability among black South Africans from different ethnic groups. 
a study performed in Nigeria found renal disease (proteinuria or abnormal serum creatinine) in 38% of 
400 patients. among the ten renal biopsy samples collected, the majority displayed the hallmarks of 
collapsing focal segmental glomerulosclerosis. In Cote d’ivoire, a study compared patients with HIV 
living in Paris, France, with patients living in Abidjan, Cote d’ivoire, and found the prevalence of 
albuminuria was higher in the cohort from Abidjan (26%) than from Paris (5%).37 a study in Tanzania 
found albuminuria to occur more frequently in patients with HIV(28.4%) than in patients without HIV 
(16.8%).A Kenyan study screened 216 ART-naïve patients with an average CD4+ T-cell count of 383 
cells/mm3. 25% had estimated GFR <90 ml/min/1.73 m2, 2% had estimated GFR <60 ml/min/1.73 
m2 and 8% had proteinuria >1 g per day. 
A Ugandan study of 229 patients with WHO clinical stage 3 for HIV showed estimated GFR to 
be under 80 ml/min/1.73 m2 in 48.5% of patients; 20% of patients had proteinuria over 100 mg/dl.40 
another Ugandan study assessed the effect of highly active art (HAART) on renal function. in this 
study 508 patients with HIV and creatinine clearance >0.42 ml/s (25 ml/min) were evaluated before 
HAART initiation: 8% of participants had serum creatinine >133 μmol/l and 20% had creatinine 
clearance between 0.42 ml/s (25 ml/min) and 0.84 ml/s (50 ml/min).After 2 years of HAART the 
median serum creatinine level decreased by 16% and the median creatinine clearance increased by 
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21%. the median creatinine clearance of patients with renal dysfunction at study initiation (that is, 
creatinine clearance 0.42–0.84 ml/s [25–50 ml/min]) increased by 53%. in multivariable analysis, 
baseline creatinine above 133 μmol/l, weight gain of more than 5 kg at 2 years, female gender and 
WHO stage 4 HIV were all associated with greater improvements in creatinine clearance. The 
development of antiretroviral therapy (Dart) study was carried out at centers in Uganda and 
Zimbabwe. Of the 3,316 participants, 45% had estimated GFR between 60 ml/min/1.73 m2 and 90 
ml/min/1.73 m2 and 7% between 30 ml/min/1.73 m2 and 60 ml/min/1.73 m2 before starting ART.  
In a Zambian study of 25,799 patients treated with art 33.5% had renal dysfunction. Of these 
participants, 3.1% had creatinine clearance <0.50 ml/s (30 ml/min), 23.4% between 0.50 ml/s (30 
ml/min) and 0.99 ml/s (59 ml/min) and 73.5% between 1.0 ml/s (60 ml/min) and 1.49 ml/s (89 
ml/min). Renal dysfunction was associated with increased mortality at 90 days. What is clear from 
these studies is that renal dysfunction is common in patients with HIV from sub-Saharan Africa, and 
although dysfunction seems to be a predictor of poor outcome, it responds to ART.  
Results from the few studies that have reported histology data seem to indicate that there could 
be a wider spectrum of histological lesions with a higher number of immune-complex diseases in sub-
Saharan African patients than among black patients from developed countries. Outcomes in patients 
with HIVAN have been correlated with the clinical stage of their disease, suggesting that survival 
improves with early detection of the condition. Relative risk of all-cause mortality increases 2.5–3.0-
fold if Hivan is associated with proteinuria, after correcting for other risk factors. In one study, 77% of 
renal abnormalities consistent with HIVAN developed in patients with CD4+ t-cell counts above 200 
cells/mm3. 
A similar outcome was also observed in a study from South Africa, where the mean CD4+ 
Tcell count of patients with biopsy-proven Hivan was 232 cells/mm3.33 a CD4+ T-cell count below 
200 cells/mm3 cannot, therefore, be used as a diagnostic criterion for Hivan. Steel Duncan et al 
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reported 2008 from Jamaica urinary tract infections were reported in 16.8% patients with HIV children 
and Ecoli was the most isolated, 4/7 developed indinavir associated nephropathy and tubulo interstitial 
diseases, six had HIVAN five were males, all had nephrotic proteinuria and 3 with chronic renal 
failure in a group of 196 children followed over, and had a high mortality 50% with a mean follow up 
of 3.1yrs. 
 Keerkirat Praditpornsilpa reported in1999 the renal pathology and HIV infection in Thailand. 
The existence of a human immunodeficiency virus (HIV) associated nephropathy (HIVAN) as a 
distinct disease entity characterized by glomerulosclerosis is well established in North America and 
Western Europe. Although the large number of HIV infected cases overwhelms the Asian countries 
biopsy studies were not many to conclude the HIVAN incidence in Asian population of HIV affected. 
Researchers have studied 26 cases of HIV infected Thai patients with proteinuria more than 1.5g/dl of 
protein during 1995 and 1996. None of the patients was treated with antiretroviral drugs at the time of 
renal biopsy. Intravenous drug addiction and sexual transmission were risk factors in 11 and 15 
patients, respectively.  
 Pathological examinations were performed by light microscopic and immunoperoxidase study. 
Mesangial proliferative glomerulopnephritis was found in 17 cases, immunoglobulinA (IgA) 
nephropathy in 2 cases and diffuse proliferative glomerulonephritis and interstitial nephritis secondary 
to Cryptococcus infection in 2 cases each. One case each had membranous glomerulopathy, 
membranoproliferative glomerulonephritis and granulomatous interstitial nephritis secondary to 
tuberculosis. The renal pathological findings of HIVAN with the unique features described in previous 
literature were not evident in these patients. Although the data in this study are limited to the 26 HIV 
infected patients, we believed that HIVAN is uncommon in the Asian HIV infected population. Renal 
biopsy study reported from northern Italy in 2009 0f 73 renal biopsies, it was found HIVAN in 9 
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cases, immune complex glomerulonephritis in 40 cases, 13 non collapsing FSGS and various others in 
the remaining.  
 Amandi mocroft et al in 2007 reported the incidence of chronic renal failure in HIV patients. 
They screened 4474 patients and found the incidence of CKD in 158 (3.5%) patients by cock croft 
gault and 209(4.7%) with MDRD at baseline, with higher incidence in patients receving indinavir and 
tenofovir. Andre kabanda et al in 1996 reported the high incidence (82.6%) of low molecular weight 
proteinuria in HIV patients, they include albumin, beta 2 microglobulin, retinol binding protein, acetyl 
beta D glucosaminidase and clara cell protein (CC16). Agati et al 2009 reported the incidence of renal 
lesion in HIV in the era of HAART, that HIVAN and glomerulonephritis were the frequent in 89 HIV 
patients evaluated postmortem. Early FSGS was identified and others include parenchymal infections 
bacterial and fungal causing chronic pyelonephritis. 
        Rao et al 1984 reported nephrotic syndrome with FSGS in nine HIV infected individuals. PP 
varma reported in 2000 proteinuria in 17.6% of 142 patients screened, none in nephrotic range, 
mesangioproliferative in 8, FSGS in 4, HIVAN in 1, 2 cases of cryptococcal infiltration and one with 
lymphomatous deposits. one with granuloma and 3 with mononuclear infiltration.  HariJanahiraman 
et al reported from Chennai in 2008 after studying 104 HIV patients, urine albumin by dipstick 
performed renal biopsy with albuminuria 2+ or more albuminuria was observed in 27% of patients, 
which revealed negative correlation with CD4 cell counts. Patients  with CD4 count <350 cells/cmm 
had a 3 folr increase in proteinuria, and there was no significant correlation with development of 
proteinuria and albuminuria had a negative correlation with hemoglobin levels.10 patients undergone 
renal biopsy and 7 had HIVAN, chronic intertstitial nephritis(CIN) in 1,membranous nephropathy in 
1,diffuse proliferative glomerulonephritis in 1 patient. NP Sing et al reported in 2005 the usefulness of 
renal biopsy in patients suspected to have HIVAN, but the predictivity in only 55 to 60% of renal 
biopsies. 
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Background of study 
 In India the free supply of ART drugs to all the HIV patients since 5 years has improved 
quality of life as well as the life expectancy of HIV population. Although the opportunistic infective 
complications secondary to HIV infections have come done dramatically, the evidences are not many. 
Few international studies gave a more or less a comprehensive picture of renal lesions in HIV-AIDS 
patients. There are specific renal renal lesions in HIV due to HIV infection. There are definite reports 
of  decreased incidences of HIV related renal lesions in the ART era. The nephrotoxicity of ART 
drugs are important contributing factors for the development and progression of renal lesions in era of 
HAART. Certain non modifiable factors such as  Age, Sex ,Race, Genetic factors, and modifiable 
factors such as diabetes hypertension, smoking, hyperlipidemias, alcohol intake, time of initiation of 
ART , and other factors as in general population are most  important in  the initiation and progression 
of renal lesions. The increased life expectancy contributes to the number of patients with chronic 
kidney disease  and  patients seeking treatment for end stage renal disease secondary to renal lesions in 
HIV-AIDS population. The benefits are as comparable to non HIV patients for dialysis requiring CKD 
HIV patients. Data of Renal transplantation and the additional benefits of CNI drugs in ESRD of HIV 
group are emerging and studies highlighted the near comparable survival in HIV population. 
Overall only few studies are available for pattern of renal lesions in the Indian subcontinent   
and few studies based upon clinical profile and others with pathological correlations.  The profile of 
renal lesions with renal biopsy is not extensively studied in this part India with a higher prevalence 
rate of HIV infection .So this study of renal lesions in HIV patients was planned to be carried out to 










AIM OF THE STUDY 
 
1. To study the Profile of Renal diseases in HIV patients. 















Materials and Methods   
         The study protocols were approved by The Institutional Review Board of Government Hospital 
for Thoracic Medicine, Tambaram at Chennai, and also by the Ethical committee for research studies 
of Government Kilpauk Medical College Hospital Chennai. Informed consent was obtained from the 
proposed study group of seven thousand three hundred and sixty three (7363) patients. The study 
protocols include recruitment of patients diagnosed to have HIVat the HIV clinic as well as inpatients 
from the above institutions. All the consecutive patients excluding  those aged  below 15 years   were 
screened for renal lesions and assigned separate serial number. The patients include persons  newly 
diagnosed to have HIV  those HIV patients who are not on ART because of CD4 above 200cell/cmm, 
as well as those on ART drugs. Initially all of them were investigated with urine analysis for protein, 
sugar, and deposits for Red Blood Cells, Pus cells, Casts and crystals .Urine protein was done by 
sulphosalisylic acid method and or dipstick. Other screening laboratory investigation was serum 
creatinine. Serum creatinine was done using Jaffe’s method. 
 Patients with  proteinuria of >500mg/day, hematuriua >5RBCs/HPF, pathologic casts in urine, 
serum creatinine of >1.2mg/dl and GFR of <60ml/mt were evaluated further. This include repeat  
urine analysis, spot urine protein and creatinine ratio, 24 hours urine protein, urine culture and 
sensitivity, complete blood count  (ncluding total and differential WBC count, hemoglobin, total RBC 
count, ESR, platelet count , bleeding time, clotting time,  fragmented RBCs, and toxic granules in 
WBCs,), blood sugar, blood urea,  serum creatinine, serum electrolytes , serum total protein, serum 
albumin, CD4 count, HbsAg, AntiHCV, complements C3,and C4, and ultra sonogram of kidneys and 
abdomen .Ultra sonogram evaluation of kidney size, parenchymal thickness, and echogenicity were 
done. Patients who were identified as acute renal failure were excluded for renal biopsy. Patients with 
severe illness associated with respiratory, cardiac, pulmonary, neurological systems and hemodynamic 
instability were  excluded from renal biopsy. Patients with reversible causes of renal failure, which 
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include prerenal, renal and post renal causes were identified, and treated . Six patients required 
peritoneal dialysis prior to renal biopsy. After consent for renal biopsy patients were admitted in 
nephrology ward. Ultra sonogram guided renal biopsies were done using biopsy gun of Bard maxcore 
renal biopsy instrument.  The renal biopsy study included light microscopy  and immunoflourescence. 
Results  
           Total number of HIV population screened was 7363 patients. Of this 864 persons are from 
Government Kilpauk Medical College Hospital and the remaining major group of patients were  from 
Government Hospital for Thoracic Medicine, Tambaram, Chennai. The analysis of this study involves 
both the groups together. 
          Of the 7363 patients, males were predominant. 4941were males ,2411 were females and 10 were 
Trasgenders.. In the males 126 were less than 20 yrs of age, 346 patients were of 20 to 29 yrs of age, 
1863 were in the 30 to 39 yrs of age, 1972 were in 40 to 49 yrs of age, 452 were in the 50 to 50 yrs of  
age, and 183 patients were 60 and above yrs of age. In the females 66 were less than 20 yrs of age, 400 
were in 20 to 29 yrs of age, 1109 in 30 to 39 yrs of age, 671in 40 to 49 yrs of age, 130 patients were in 
5o to 59 yrs and 49 were above age of 60 yrs.  
 These groups were further sub classified into patients receiving drugs for retro virus (ART) and 
those who are not receiving retroviral drugs (non ART).The group of patients receiving ART include 
four thousand nine hundred and sixty persons and in this group three thousand five hundred and thirty 
five were males, one thousand four hundred and twenty five were females and trans genders were five. 
Two thousand four hundred and eight not received ART drugs of them one thousand four hundred and 
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TABLE - II 
Initial group of 7363 patients proteinuria evaluation revealed 2581 patients had proteinuria 
from trace to 4+. Of them 1905 were males and 676 were females. In the males 829 had trace 
proteinuria, 661 had 1+ proteinuria, and 292 had 2+ proteinuria, 165 had 3+ proteinuria and 13 had 4+ 
proteinuria. In the females of the screened of 2411 patients 358 had trace proteinuria, 219 had 1+ 
proteinuria, 74 had 2 + proteinuria, 23 had 3 + proteinuria and only 2 had 4+ proteinuria. 
         In the sub group results of the proteinuria group of the 2581 males, in those who were below 20 
yrs of age, 4 had 1+ proteinuria, 30 had 3+ proteinuria. In the males  of the 20 to 29 age group of 346 
patients, 69 had trace proteinuria,  43 had 1 + proteinuria, 8 had 2 + proteinuria, 10 had 3+ proteinuria. 
In the 30 to 39 age group 1863 patients, 248 had trace proteinuria, 252 had 1 + proteinuria,150 had 2 + 
proteinuria, 64 had 3 +  proteinuria  and 4 had 4 + proteinuria. In the 40 to 49 age group of 1972 
patients, 430 had trace proteinuria, 182 had 1+ proteinuria, and 92 had 2 + proteinuria, 45 had 3 + 



















proteinuria, 112 had 1+ proteinuria, and 26 had 2+ proteinuria, and 16 in the 4+ proteinuria range. Of 
the183 patients of 60 yrs and above, 6 had trace proteinuria, 26 had 1+ proteinuria, 16 had 2+ 
proteinuria and none in the 3+ and 4+ groups. 




Age Nil Trace 1+ 2+ 3+ 4+ Total 
< 20 92 0 4 0 30 0 126 
20 – 29 224 69 43 8 10 0 346 
30-39 1165 278 294 150 64 4 1863 
40-49 1114 430 182 92 45 9 1972 
50-59 252 46 112 26 16 0 452 
>= 60 135 6 26 16 0 0 183 
Total 2982 829 661 292 165 13 4942 
 








































Age Nil Trace 1+ 2+ 3+ 4+ Total 
< 20  51 12 5 2 1 0 71 
20 - 29 225 121 33 16 2 0 397 
30-39 764 195 104 31 12 1 1107 
40-49 531 28 69 16 6 2 652 
50-59 105 12 7 9 2 0 135 
>= 60  36 6 2 4 1 0 49 
Total 1712 374 220 78 24 3 2411 
 










                          Total of 2411 female patients were screened for proteinuria. In  the less than 
20 yrs of age group of 66 persons, 12 had trace proteinuria, 5 had 1+ proteinuria, 2 had 2+ proteinuria, 
1 had 3+ proteinuria and none in the 4 + proteinuria group. In the 20 to 29 yrs group of 400 patients, 
121 had trace proteinuria, 33 had 1+proteinuria, 16 had 2+ proteinuria, and 2 had 4+ proteinuria. In the 
30 to 39 yrs age group of 1109 patients, trace proteinuria in 195, 1+ proteinuria in 104, 2+  proteinuria 
in 31, 3+ proteinuria in 12, and  4+ proteinuria in 1. In the 40 to 49 age group of 652 patients, 28 had 
trace proteinuria, 69 had 1+ proteinuria, 16 had 2+  proteinuria, 6 had 3+  proteinuria, and 2 had 4+ 
proteinuria. In the 50 to 59 group of 135 patients 12 had trace proteinuria, 7 had 1+ proteinuria, 9 had 
2+ proteinuria, 2 had 3+ proteinuria and none with 4+ proteinuria. In the age group of 60 yrs and 
above of 49 patients 6 had trace, 2 had 1+ , 4 had 2+, 1 had 3+ proteinuria and none in the 4+ group. 
Due to logistical reasons quatitatification of proteinuria was done only in 563 patients, of these 
significant proteinuria in the range of 300mg to 500mg were found in 114 patients and proteinuria in 
the range of more than 500mg to 1000mg were found in 85 patients, subnephrotic proteinuria in the 
range of 1gram to 3grams was found in 72 patients, nephrotic range proteinuria was found in 27 
patients. 
336 patients of the 7363 screened had hematuria. Microhematuria was detected in 318 patients 
and macrohematuria in 18 patients. Patients with microhematuria 3 and 4 cells /HPF detected in 156 
persons , 5 to 9 cells /HPF in another 156 patients and in 6 patients ≥ 10cells/HPF. 
Of the 7363 urine for pus cells study 1203 had significant pyuria of more than 5 
WBCs/HPF,urine culture was done only for in patients , Ecoli was grown in 28 patients  Pseudomonas 









TABLE - V 
 
Total Screened                  7363 
Hematuria  detected 336 
Micro Hematuria detected 318 
Macro Hematuria detected 18 
3 to 4 RBCs / HPF 156 
5 to 9 RBCS / HPF 156 




























3 to 4 RBCs /
HPF
5 to 9 RBCS /
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≥ 10 cells /
HPF

































Urine Protein Creatinine Ratio 
 
TABLE - VI 
 
(UPCR Total No of Patients 
0.3 to ≤  0.5 114 
> 0.5 to 1.00 85 
> 1.00 to < 3.00 72 
≥  3.00 27 
Total Significant 298 





 Of the 7363 patients who had undergone screening for creatinine 574 were found to have renal 
failure as evidenced by elevated serum creatinine of 1.3mg/dl .  Of all the 574 patients who had 
elevated creatinine 489 were males and 85 were females and 1 was a transgender. They were 
subclassified by the level of serum creatinine into 3 groups – the first group with serum creatinine 1.3 
to 2 mg/dl, second group from 2mg/dl to 4mg/dl and the third group above 4mg/dl. Again these groups 
were divided based on the age. The age wise sub classification include <20, 20 to 39, 40 to 59, ≥60. In 
the males group, of the 489, 330 persons had serum creatinine 1.3 to< 2mg/dl, 113 had serum 
creatinine 2 to 4 mg/dl and 46 had 4mg/dl and above. In the 1.3 to 2mg/dl group one patient was <20 
yrs, 118 were in the 20 to 39 yrs group, 178 were in the 40 to 59 yrs age group and 33 were above 60 
yrs of age. In the 2 to 4mg/dl group 39 persons belong to 20 to 39 yrs of age, 60 were in 40 to 59 age 
group and 14 persons are above 60 yrs. In persons with 4mg/dl and above 16 belong to 20 to 39 age 
group, 30 belong to 40 to 59 age group.   In the females 1belongs to < 20 yrs of age, 22 belong to 20 to 
39 yrs of age 20 belong to 40 to 59 yrs age group and 5 were above 60 yrs in the 1.3 to 2mg/dl group.  
                            
In the other group with 2 to 4mg/dl creatinine 1 was < 20 yrs 5 were 20 to 39 yrs of age 13 
belong to 40 to 59 yrs age group and 1 was above60 yrs. In the females with serum creatinine 4mg/dl 
and above 6 belong to 20 to 39 age group and 11 belong to 40 to 59 age group.  
Electrolyte Abnormalities 
  Serum sodium measurements  were done in 143 patients, they had the serum sodium 
level range of 121meq/l to 143meq/l. 78 persons had hyponatremia below the level of 135meq/l, of 
them 5 had severe hyponatremia below 125meq/l. Serum potassium was done in the same 143 patients 
and the range was from 2meq/l to 5.2 mq/l. 20 patients had serum potassium levels below 3mq/l. 33 
patients had below 3.5mq/l. Acute renal failure presented as pre renal ATN and post renal was the 




TABLE - VII 
 
RENAL FAILURE DETECTED 
 
 
Total Number Screened   :  7363 
 
Total with Renal Failure   : 574 
 
No of Males with Renal Failure  :  489 
 
No of Females with Renal Failure  :  85 
 
 
Sr. Creatinine Age Males Females Total 
1.3 to 2 mg /dl 
< 20 1 1 2 
20-39 118 22 140 
40-59 178 20 198 
> 60 33 5 38 
2 to 4 mg / dl 
< 20 0 1 1 
20-39 39 5 44 
40-59 60 13 73 
> 60 14 1 15 
>4 mg / dl 
< 20 0 0 0 
20-39 16 6 22 
40-59 30 11 41 







Kidney Size in Patients with HIV with Renal Lesions 
 The 574 patients’ kidney size was evaluated with ultrasound, who had either significant 
proteinuria or renal failure or both. Of these 29 kidneys on right side and 24 on the left side were  
<9cms. Bilaterally contracted kidneys in 13 patients, asymmetric kidneys in 11 patients were present.   
 And the remaining 434 patients had kidneys of the size of more than 9cms bilaterally. The range of 
the kidney size varied from 9 to 15.16cms with a mean of 10.78cms and median of 10.7cms.  Bilateral 
contacted kidneys and asymmetric kidnerys noticed in  40 patients  
 Renal stones were identified in 7 0f 510 USGs and in 4 four they received ART. 42 patients 
had evidence of UTI and urosepsis.   Total patients of HIV with renal failure expired  was 40 and of 
this 26 patients with HIV expired had renal insufficiency with multiple organ involvement and in 14 
the cause of death was chronic renal failure and related complications one patient on maintenance 
hemodialysis, and  4 had  peritoneal dialysis once. 
 Patients with renal failure with normal size kidneys, patients with proteinuria of 500mg and 
above and patients with more than 5 and above RBCs were advised to undergo evaluation in the form 
of renal biopsy and serological profile for hepatitis B, C and in selected cases C3 and C4. Number of 
patients eligible for biopsy as per our screening study was 651, which include patients with micro 
hematuria more than 5 RBCs /HPF  proteinuria of >500mg/day , and with renal failure . Due to both 
medical and socioeconomic reasons biopsy could not be done to all selected patients.  
  The number of renal biopsies done was 72 in 71 patients.(one patient required rebiopsy )  
Nmber of males who underwent  renal biopsy was 59,  females  11,and transgender  1. Total number 
of patients on ART 36 and patients not on retroviral drugs was 35. Total number of males on ART was 
 54 
33, and for females it was 3. Total   number of males not on retro viral drugs was 26 and in females it 
was 8 and 1 in transgender. 




ARF  128 
PRE RENAL 114 
RENAL ATN 10 
POST RENAL 4 
Total No. screened with Renal Failure 574 
 
 
TABLE - IX 
CKD IN HIV PATIENTS 
STAGE OF CKD MALES FEMALES TOTAL 
CKD 3 172 (54.7%) 78 (59.09%) 250 (56.05%) 
CKD 4 108 (34.48%) 40 (30.31%) 148 (31.18%) 
CKD 5 34 (10.82%) 14 (10.60%) 48 (12.77%) 
TOTAL 314 (100%) 132 (100%) 446 (100%) 
 
Of the 71 patients who had undergone renal biopsy the indication for renal biopsy was renal 
failure with serum creatinine of ≥1.3 mg/dl was  in 59,  in the males it was 52, in the females it was 6 
and 1 in transgender . Patients taken up for renal biopsies for proteinuria of ≥500mg/day were 12, of 
this 7 were males and 5 were females. Though we intended to use microhematuria of ≥ 5 RBCs /HPF 
as indication for renal biopsy there other indications too in these patients such as ≥1.3mg/dl of serum 




Light microscopy  
 Upon light microscopy, mesangial cell hypercellularity was seen in 57 of the 72 biopsies. 
Mesangial matrix expansion was seen in 17 biopsies which was mild in 16 and moderate in 1 patient. . 
Ischemic vascular changes seen in glomeruli in 28 biopsies, which was mild in 25 and moderate in 3 
biopsies. Tubular atrophy was seen in 38 biopsies of which focal tubular atrophy in 22 biopsies and 
moderate tubular atrophy in 13 biopsies and severe tubular atrophy in 3 biopsies. Interstitial dense 
infiltrate of lymphocytes and other mononuclear cells were found in remarkably high number of 
patients of 42 renal biopsies. It was mild in 2 biopsies, dense patchy in 38 biopsies and diffuse dense 
in 2 biopsies. 
  Interstitial nephritis seen in 18 biopsies, 1 had AIN, one had ATIN, and 2 had sub acute 
interstitial nephritis and remaining 15 had chronic interstitial nephritis. Marked interstitial fibrosis 
seen in 7 biopsies. ATN features with tubular cell flattening, apoptosis, tubular dilatation seen in 5 
biopsies. feature of pyelonephritis seen in 2 biopsies. Features of arterio and arteriolo sclerosis were 
seen in 15 biopsies.  
 
Immunoflourescence  
          IgG deposits in glomeruli in the mesangial and capillary walls were seen in 16 biopsies, 2+ seen 
in 3 biopsies,3 + in seven biopsies, 4+ in 5biopsies.  
 IgM deposits was seen in glomeruli in 54 biopsies, 1+ in seven biopsies, 2+ in twenty four 
biopsies, 3+ in fourteen biopsies, and 4 + in seven biopsies.  
 IgA deposits were seen in 13 biopsies and in 11 of them it was dominant or codominant. Three 
had 1+ deposits in glomeruli and 4 had 2+ deposits, 3 had 3+ and 3 had 4+ deposits in glomeruli. 
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  C3c deposits were seen in 52 biopsies, 2+ pattern in 12 biopsies, 3+ in 13 biopsies, and 4+ 
deposits in 27 biopsies. 
 C1q deposits were seen in 13 biopsies, of this one had 1+ deposit in glomeruli, seven had 2+ 
four had 3+, and one  had 4+ deposits in glomeruli.  
 Fibrinogen deposits of 4+ was seen in one glomeruli. 
Biopsy Diagnosis 
 Diffuse mesangial proliferation (DMP) was seen in 26 renal biopsies  
 HIVAN was clearly evident in 21 biopsies and in them 7 had early features of partial collapse. 
 Classical FSGS was seen in 6 biopsies. 
 IgA nephropathy was seen in 11 biopsies. 
            IgA with HIVAN was seen in 5 biopsies 
 Membranous nephropathy was seen in 2 biopsies. 
 Lupus nephritis with membranous, diffuse proliferative and crescents were  seen in 1 patient.  
 Lupus like nephritis was seen in 1 biopsy. 
 Vasculitis with crescent in one patient, and  
 IgA with crescent was seen in one patient. 
            PIGN in 3 patients 
 ATN in 5 patients 
 Interstitial nephritis seen in 18 biopsies. 






































































































































































 DISCUSSION OF THE STUDY 
 It is one of the largest studies involving 7363 HIV patients, with a male female ratio of 
approximately 2:1. Of the total of 7363 screened, 2581 had proteinuria, which corresponds to 
35.5%.of the screened, this incidence was compared and found that it very well correlates with the 
records available from other centres  which vary widely   up to 30% . Quantification of proteinuria 
was done in 563 patients, of them 298 had proteinuria above 3oomg/day. It suggests high incidence of 
significant proteinuria in screened HIV patients. 
Out of the 7363 screened HIV patients, 336 were found to have hematuria, constituting about 
4.5%. This level of detection of hematuria is not reported in any other studies.  574 patients had renal 
failure which constitutes about 7.79% of the HIV patients screened and of this 128 patients had 
evidence of acute kidney injury ARF due to  pre renal, ATN  and  post renal causes constituting of 
about 1.75%.  In contrast the  studies of ARF reported by Peraldi et al in 1999 and others during the 
 62 
same period which were around 4 to 5%. The earlier studies reported incidence of ARF up to 20% in 
pre ART era.  
Though good health care facilities are available for early detection of HIV, this high incidence  
of renal failure in HIV could be attributed to the psychosocial behaviour of the patient and the timing 
of decision for evaluation and treatment.  The incidence of sepsis including due to urinary tract 
infection was 42 of the 574 followed up patients which constitute of about 7.4%. 
Only 72 biopsies were done because of socioeconomic reasons. In this group Diffuse 
mesangial proliferation was present in 26 renal biopsies and is the major group. The high incidence of 
this group with DMP  could be due to the early evaluation of patients. This is followed by HIVAN in 
21 patients,   IgA nephropathy in 11 patients and both concomitantly present in 5 patients.  This 
signifies the diversity of acute and chronic glomerular lesions with immune complex deposition.  
6 patients who had partial tuft collapse could be explained by 2 factors.1) the progression of 
HIV renal lesion due to renal tropic viruses not much affected by the ART. 2) There could be arrest of 
renal lesions of HIVAN at the level when patient started on ART. Further studies may explain this 
issue.  When analyzing  with lupus nephritis class 4& 5 with crescents and HIVAN not found in the 
literature were seen. HUS was not seen in the initially evaluated as well as biopsied group of patients. 
Total number on ART in the study group of renal biopsy was 36, of this males were 33, and 
females were 3 in number, and in the non ART group there were 25 males, 8 females and 1 trans 
gender. When CD4 count was matched with the biopsied group the range of CD4 cells was 41 to 618 
with a mean of 196 .6, median of 168 and with S.D of 123.22 in 36 patients. In the non ART group of 
34, 31 had renal failure and the CD4 count in this group was with a range of 41 to 618 cells, mean of 
197.45, and median value of 168 with S.D of 126.57. In the other group without renal failure on non 
ART of 3 patients the range was 78 to 275 and median of 210 and a mean of 187. 
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RENAL BIOPSY RESULTS 
Serial No 
 











Classical FSGS 6 
4 
 
IgA Nephropathy 11 
5 
 
IgA with HIVAN 5 
6 
 
Membranous Nephropathy 2 
7 
 
Lupus Nephritis  1 
8 
 






RPGN -Crescents 3 
11 
 






Interstitial Nephritis 18 
14 
 
Acute Interstitial Nephritis 1 
15 
 
Acute Tubulo  Interstitial Nephritis 1 
16 
 
Sub Acute Interstitial Nephritis 2 
17 
 
Acute Pyelo Nephritis 2 
18 
 
Chronic Interstitial Nephritis 15 
19 
 
TB Granuloma 1 
20 
 
Total NO. of Biopsies 72 
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HIVAN for Statistical Analysis 
Null hypothesis (H0):    There is no significant difference between HIVAN, Non ART, HIVAN Rt Kidney, 
HIVAN Lt Kidney, HIVAN RF / CD4, Sr. Creatitine, PCR and Total CD4, HIVAN of the experimental group  
 
One-Sample Test FOR HIVAN WITH KIDNEY SIZE,SE_CREATININE,URINE PCR AND CD4 
HIVAN 
GROUPS 
                                    
t df p-value Mean Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
HIVAN Non ART 8.686 30 .000 197.45161 151.0241 243.8792 
HIVAN_Rt Kidney 33.898 20 .000 10.48095 9.8360 11.1259 
HIVAN Lt Kidney 46.778 20 .000 10.19190 9.7374 10.6464 
HIVAN RF  / CD4 6.252 18 .000 253.36842 168.2285 338.5083 
Sr. Creatitine 4.670 20 .000 3.29048 1.8208 4.7602 
PCR 5.287 20 .000 1.65571 1.0025 2.3090 
Total CD4 HIVAN 6.886 20 .000 252.33333 175.8942 328.7725 
Interpretation: 
 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that There is a significant difference between HIVAN non art of the 
experimental group with cd4. 
 
 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that there is a significant difference between Right kidneys of the 
experimental group. 
 
 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that there is a significant difference between left kidneys of the experimental 
group. 
 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that there is a significant difference between SE_CR, of the experimental 
group with cd4 count in HIVAN. 
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 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that there is a significant difference between, urine pcr of the experimental 
group in HIVAN. 
 
 Since p-value is LESS than 0.05, we reject the null hypothesis at 5% level of significance. 
Hence we can conclude that there is a significant difference between CD4 VALUES of the 
experimental group with HIVAN analysed in total. 
 
When CD4 was matched with ART and renal lesions of 36 patients who had done renal biopsy, 
the CD4 range was 20 to 650 with a median of 160, mean of 200.91 and S.D of 146.44. This group 
divided into with or without renal failure of 27 and 9 patients respectively. When CD4 was matched 
without renal failure of 9 patients in ART group the results available was, the range of CD4 cells was 
32 to 252, with mean of 162.4 with S.D of 70.4 and median of 160.  In the other group with ART, 
CD4 and renal failure the range of CD4 was 20 to 63, median of 160 and mean of 213.74 with S.D of 
163.20. 
When these patients were analysed   21 HIVAN patients with CD4 counts, of them 18 were 
males and 3 were females. The range of CD4 was 41 to 650, median of   178, and mean of 252.33 with 
S.D of 167.92. Out of 21 HIVAN 19 had renal failure. This group was further divided based upon 
serum creatinine into three and analyse with CD4.The groups 1.3 to 2 mg s serum creatinine 
r.creatinine ,>2mg to 4 mg/dl og serum creatinine and above 4 mh/dl of serum creatinine. In the first 
group of 1.3 to 2 mg/dl the CD4 range was 99 to 650, median of 172, mean of 290.22 and S.D of 
208.77. In the second group with serum creatinine of >2mg/dl to up to 4mg/dl the range was 41 to 
394, median was 123.5,mean of 172.66 and S.D of 138.22. In the last group of serum creatinine above 






This study is one of the largest studies of HIV patients evaluated for Renal lesions           
 7363 HIV patients were screened   over a period of two years (2008 to 2010). Of them 
      4942 were males,  2411 were females and  10 were transgenters and the male female ratio  
      was 2.05 :1 
 Significant Proteinuria  was present in 2582(35.5%) patients  
 Hematuria was found in 336 (4.5%) of  patients, of them 18 had macroscopic hematuria. 
 Renal failure was detected in 574 patients (7.79%)  
 Acute Kidney Injury was detected in 128 patients (1.75%) 
 446 patients had chronic kidney disease in Stages 3 - 5  and of this 314(70.41%) were  
      males and 132  (29.59%) were females. 
     250 Patients were in Stage 3 CKD, 148 in Stage 4 CKD and 48 in Stage 5 CKD 
    14 Patients died of ESRD and one patient is on maintenance hemodialysis. 
 Type 2 Diabetes was the cause of CKD in 24 patients. 
 Hypertension was seen in 66 of the 574 patients with renal failure. 
 4 Patients had Hepatitis B and 2 had hepatitis C. 
 Pyuria was seen in 1203 (16.33%) patients of the 7363 screened.      
 Urinary tract infection (UTI) was documented in 42 of the 574 patients in whom urine culture 
was done. E.Coli was the commonest organism isolated in 66.66% followed by Pseudomonas 
and Klebsiella of 16.33% each.    
 Of the 72 renal biopsies performed DMP was the commonest lesion encountered (35.5%) 
 Other common lesions were HIVAN (29.1%) and IgA Nephropathy (15.49%) 
 A rare combination of Lupus nephritis (class 4&5 with crescents) and HIVAN was seen in  
     one patient 
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 Statistically significant correlation was observed between CD 4 count and HIVAN in patients 
who were not on ART. 
                      Early identification of patients with renal lesions will help to prevent progression of 
kidney disease so it is recommended to screen HIV patients for proteinuria, hematuria and renal 
insufficiency once in three months.  Early initiation of ART is to be considered in those with renal 
abnormalities.  
 Infrastructure is required for management of the patients of HIV who develop End Stage 
Renal Disease (ESRD) and who require renal replacement therapy in the form of dialysis including 
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